Novo Nordisk eyes bolt-on deals as pipeline disappointments pile up
“If you don't like setbacks and you don't like failure, don't get into the pharma industry,” Novo Nordisk CEO Maziar Mike Doustdar said on a call with media Wednesday. The implication was unintended, but anyone ...
Mike Doustdar, Novo Nordisk CEO (Michael Nagle/Bloomberg via Getty Images) August 5, 2026 07:06 AM EDTUpdated 08:11 AM Pharma Novo Nordisk eyes bolt-on deals as pipeline disappointments pile up Elizabeth Cairns Senior biopharma journalist “If you don’t like setbacks and you don’t like failure, don’t get into the pharma industry,” Novo Nordisk CEO Maziar Mike Doustdar said on a … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that